Study S001825

Effects of Combined Menopausal Hormone Therapy and GLP-1 Receptor Agonist Therapy on Glucose and Energy Homeostasis in Early Postmenopausal Women With or at Risk of Diabetes

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06715514
Acronym: DECLARED-CT
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: NONE
Status: ACTIVE_NOT_RECRUITING
Enrollment: 96
Start: 2025-02-18
Primary completion: 2026-12-17
Lead sponsor: Lia Bally
Conditions: Menopause; Type 2 Diabetes
Interventions: DRUG:GLP-1 Receptor Agonist; DRUG:Menopausal Hormone Therapy
Results posted: FALSE
Individual participant data sharing: YES
Secondary identifiers: OTHER_GRANT:10000574; REGISTRY:2024-01882

Registered primary outcomes

Change in HbA1C [12 Weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.